World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
120
Citations
56948
World Ranking
632
National Ranking
403

Gary L. Johnson publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Gary L. Johnson sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 575 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Gary L. Johnson D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Gary L. Johnson sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 120 D-Index — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Gary L. Johnson is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research spans multiple disciplines, primarily focusing on Medicine and Biochemistry, Genetics and Molecular Biology. The subfields they contribute to include Molecular Biology, Oncology, Neurology, Cancer Research, and Organic Chemistry.

Their recent scholarly contributions reflect a variety of research interests and publications in prominent scientific journals. Notable papers include:

  • FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease, 2020, Journal of Clinical Investigation
  • Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial, 2021, Nature Medicine
  • New strategies for targeting kinase networks in cancer, 2021, Journal of Biological Chemistry
  • Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK, 2021, PLoS ONE
  • Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy, 2020, JCI Insight

Their collaborative work involves frequent co-authorship with several researchers, including Michael P. East, Steven P. Angus, Christopher R. M. Asquith, Timothy J. Stuhlmiller, and Shawn M. Gomez.

Gary L. Johnson's publications are predominantly found in venues such as UNC Libraries, Cancer Research, bioRxiv (Cold Spring Harbor Laboratory), Neuro-Oncology, and the Journal of Biological Chemistry.

The main topics investigated in their work cover a range of biomedical concerns, including:

  • Melanoma and MAPK Pathways
  • Neurofibromatosis and Schwannoma Cases
  • Cancer Genomics and Diagnostics
  • Protein Degradation and Inhibitors
  • Phagocytosis and Immune Regulation
  • Neuroblastoma Research and Treatments
  • Cancer Mechanisms and Therapy

Best Publications

  • Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases

    Gary L. Johnson;Razvan Lapadat

  • Mitogen-Activated Protein Kinase: Conservation of a Three-Kinase Module From Yeast to Human

    Christian Widmann;Spencer Gibson;Matthew B. Jarpe;Gary L. Johnson

  • Organization and regulation of mitogen-activated protein kinase signaling pathways

    Timothy P Garrington;Gary L Johnson

  • Differential Activation of ERK and JNK Mitogen-Activated Protein Kinases by Raf-1 and MEKK

    Audrey Minden;Anning Lin;Martin McMahon;Carol Lange-Carter

  • A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf

    Carol A. Lange-Carter;Chris M. Pleiman;Anne M. Gardner;Kendall J. Blumer

  • Coordination of Rho GTPase activities during cell protrusion

    Matthias Machacek;Matthias Machacek;Louis Hodgson;Louis Hodgson;Christopher Welch;Hunter Elliott

  • Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2

    Anning Lin;Audrey Minden;Horacio Martinetto;Francois Xavier Claret

  • Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer

    James S. Duncan;Martin C. Whittle;Kazuhiro Nakamura;Amy N. Abell

  • Mixed-lineage kinase control of JNK and p38 MAPK pathways.

    Kathleen A. Gallo;Gary L. Johnson

  • The Regulation of Anoikis: MEKK-1 Activation Requires Cleavage by Caspases

    Michael H Cardone;Guy S Salvesen;Christian Widmann;Gary Johnson

  • The c-jun kinase/stress-activated pathway : Regulation, function and role in human disease

    Gary L. Johnson;Kazuhiro Nakamura

  • Phosphorylation and activation of a high molecular weight form of phospholipase A2 by p42 microtubule-associated protein 2 kinase and protein kinase C.

    Raphael A. Nemenoff;Sim Winitz;Nan Xin Qian;Vicki Van Putten

  • Caspase-dependent Cleavage of Signaling Proteins during Apoptosis: A TURN-OFF MECHANISM FOR ANTI-APOPTOTIC SIGNALS

    Christian Widmann;Spencer Gibson;Gary L. Johnson

  • Diversity in function and regulation of MAP kinase pathways

    Kendall J. Blumer;Gary L. Johnson

  • Gα12 and Gα13 Stimulate Rho-dependent Stress Fiber Formation and Focal Adhesion Assembly

    Anne Mette Buhl;Nancy Lassignal Johnson;N. Dhanasekaran;Gary L. Johnson

  • Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation

    Daniel R. Ambruso;Cindy Knall;Amy N. Abell;Julie Panepinto

  • Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death.

    Nancy Lassignal Johnson;Anne M. Gardner;Katrina M. Diener;Carol A. Lange-Carter

  • Ras-Dependent Growth Factor Regulation of MEK Kinase in PC12 Cells

    Carole A. Lange-Carter;Gary L. Johnson;Gary L. Johnson

  • MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases?

    Gary R Fanger;Pär Gerwins;Christian Widmann;Matthew B Jarpe

  • Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation.

    B E Wadzinski;W H Wheat;S Jaspers;L F Peruski

Frequent Co-Authors

Lynn E. Heasley
Lynn E. Heasley University of Colorado Anschutz Medical Campus
Christian Widmann
Christian Widmann University of Lausanne
Erwin W. Gelfand
Erwin W. Gelfand University of Colorado Anschutz Medical Campus
Spencer B. Gibson
Spencer B. Gibson University of Manitoba
Naohiro Terada
Naohiro Terada University of Florida
David W. H. Riches
David W. H. Riches University of Colorado Denver
Kenneth L. Tyler
Kenneth L. Tyler University of Colorado Denver
Jerry A. Nick
Jerry A. Nick National Jewish Health
Peter M. Henson
Peter M. Henson National Jewish Health
Edward D. Chan
Edward D. Chan National Jewish Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens the door to a wide range of advanced degree options and career opportunities. Many students are now exploring online postgraduate programs to enhance their expertise and flexibility in learning. For example, if you are interested in nursing leadership but prefer a non-traditional route, a dnp program without clinical hours can offer valuable academic credentials without the requirement of on-site clinical practice.

For those aiming for administrative positions in healthcare settings, pursuing online doctoral programs healthcare administration can prepare you for senior managerial roles. On the clinical side, pharmacy students can consider online pharm d programs to deepen their pharmaceutical knowledge and credentials while maintaining work-life balance.

Additionally, if your interests align with physiology, fitness, or rehabilitation, various online exercise science degree options may be a solid choice, opening doors to careers in sports science, health coaching, or physical therapy. These online pathways make it easier than ever to build upon your Biology or Biochemistry background and shape a diverse array of career destinations.

Best Scientists Citing Gary L. Johnson

Trending Scientists